$GANX 🚀 +20% AH 🔹️ Gain Therapeutics receives FDA clearance of its IND for GT-02287 in Parkinson’s disease — major regulatory milestone ✅ 🔹️ IND authorizatio

$GANX 🚀 +20% AH 🔹️ Gain Therapeutics receives FDA clearance of its IND for GT-02287 in Parkinson’s disease — major regulatory milestone ✅ 🔹️ IND authorization clears the path for Phase 2 clinical development in the U.S., expected to begin in 3Q26 📅 🔹️ Phase 1 data showed favorable safety/tolera…